MHRA cracking down on organised crime worth £200m
|
The Medicines and Healthcare Regulatory Agency (MHRA) is cracking
down on the diversion of Prescription-Only Medicines (POM) onto the
criminal market, after first becoming aware of a significant
diversion of benzodiazepines and other hypnotics/anxiolytics in
2016. During 2017 MHRA expanded operations to 19 active
investigations and have made more than 40 arrests. Our...Request free trial
The Medicines and Healthcare Regulatory Agency (MHRA) is cracking down on the diversion of Prescription-Only Medicines (POM) onto the criminal market, after first becoming aware of a significant diversion of benzodiazepines and other hypnotics/anxiolytics in 2016. During 2017 MHRA expanded operations to 19 active investigations and have made more than 40 arrests. Our investigations have revealed an extensive network of criminality involving businesses such as wholesale dealers and a small number of registered pharmacies throughout the UK diverting medicines. Between 2013 and 2016 an estimated £115-200m of medicines were diverted from the legitimate supply chain onto the criminal market, putting thousands of vulnerable people at risk. The independent review into dependence and addiction to prescription drugs, recently announced by the Department of Health and Social Care, highlights the scale of the problem. The review will be looking into the results of a recent Home Office survey which found 7.6% of adults had taken a prescription-only painkiller not prescribed to them. Arrests have been made for offences such as possession with intent to supply a controlled drug, and offences under the Proceeds of Crime Act. The focus of our investigation is Prescription-Only Medicines such as benzodiazepines and anxiolytics including Diazepam and Zopiclone as well as the painkiller Tramadol. These medicines are being sold through websites acting illegally, and people should be careful when buying medicines online. Criminals are known to exploit vulnerable people by selling medicines through unregulated websites and stealing their credit card details. Self-diagnosis and self-medication can be dangerous. All of the Prescription-Only medicines currently being investigated have the potential to result in addiction. However, when these are appropriately prescribed there are measures in place to reduce this risk including restrictions on the dose or duration of treatment. There is no indication this criminality has led to medicines shortages or issues with the legitimate supply of medicines to the public and medicines supplied with a prescription, through registered pharmacies, are unaffected. Alastair Jeffrey, MHRA Head of Enforcement, said:
Victoria Atkins MP, Minister for Crime, Safeguarding and Vulnerability said:
Duncan Rudkin, Chief Executive of General Pharmaceutical Council:
|
